Rubius Therapeutics OverviewRubius Therapeutics Research & Development
Research & Development expenses for RUBY.
Quarterly R&D Expenses
$888000.00
↓ 97.77% YoY
As of Dec 31, 2022
Annual R&D Expenses (TTM)
$96.41M
↓ 31.9% YoY
Trailing 12 months ending Dec 31, 2022